Target intelligence / Profile preview

APCDD1L antisense RNA 1 (APCDD1L-AS1)

Target
APCDD1L-AS1
Molecular classification
Other (Long non-coding RNA, lncRNA)
01

Overview

APCDD1L antisense RNA 1 (APCDD1L-AS1, also referred to as APCDD1L-DT) is a long non-coding RNA transcribed in antisense orientation relative to the gene APCDD1L. The gene is categorized as a divergent transcript, suggesting it may be involved in gene regulatory events at the RNA level, possibly by influencing the chromatin structure or transcriptional activity of APCDD1L or neighboring genes through antisense interactions. At present, there is little functional or disease association data for this specific lncRNA, and it is not considered a therapeutic target. No drugs or therapeutic interventions are known to target APCDD1L-AS1/APCDD1L-DT. This transcript does not code for a protein and should not be confused with APCDD1L or APCDD1, which do code for proteins involved in WNT signaling regulation. The majority of research, including the provided search results, is about APCDD1 and its protein-coding homolog APCDD1L, both of which are WNT pathway regulators. APCDD1L-DT/APCDD1L-AS1, however, is a non-coding RNA transcript and is not established as a protein-coding gene, therapeutic target, or biomarker. It also does not fall under typical receptor, enzyme, or transporter molecular families.

Other names
APCDD1L-AS1APCDD1L-DTAPCDD1L antisense RNA 1 (head to head)APCDD1L antisense RNA 1 (non-protein coding)
02

Mechanism of action

Not applicable; there are no drugs targeting this molecule

03

Biological functions

Unknownpotentially gene expression regulation via antisense mechanisms
04

Disease associations

Not established; no robust literature associating APCDD1L-AS1/APCDD1L-DT specifically with any disease process
05

Safety considerations

None known
06

Interacting drugs

None known
07

Biomarkers

None known

Beyond the preview

Go deeper on APCDD1L antisense RNA 1 (APCDD1L-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on APCDD1L antisense RNA 1 (APCDD1L-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call